Saquinavir mesylate oral dosage form

Details for Australian Patent Application No. 2004255436 (hide)

Owner F.Hoffmann-La Roche AG

Inventors Shah, Navnit-Hargovindas; Albano, Antonio A.; Phuapradit, Wantanee; Zhang, Lin; Infeld, Martin Howard

Agent Spruson & Ferguson

Pub. Number AU-B-2004255436

PCT Pub. Number WO2005/004836

Priority 60/486,600 11.07.03 US; 60/568,204 05.05.04 US

Filing date 5 July 2004

Wipo publication date 20 January 2005

Acceptance publication date 30 November 2006

International Classifications

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/004836 Priority application(s): WO2005/004836

30 November 2006 Application Accepted

  Published as AU-B-2004255436

19 April 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255439-Inhibition of stress-induced liganddependent EGFR activation

2004255433-Bleaching of dairy products